Subgroup Analyses and Clinical Insights in Metastatic Hormone-Sensitive Prostate Cancer Treatment

from Urology Times Podcasts · host Urology Times

Jack R. Andrews, MD; Eugene B. Cone MD; and Edwin Posadas, MD, FACP, discuss how early intervention with individualized treatment approaches based on disease volume, patient characteristics, and biomarkers significantly improves survival outcomes in metastatic hormone-sensitive prostate cancer.Timecodes1:35 Individualized Care for PC9:24 Frailty & Comorbidities in PC12:27 Molecular Testing in PC18:10 Sequencing in PC22:00 Doublets/Triplets in mHSPC30:00 Subgroups in mHSPC39:00 ARASENS Subgroup Analysis43:55 Future of mHSPC Care

Episode metadata supplied by the publisher feed · Published Apr 2, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Subgroup Analyses and Clinical Insights in Metastatic Hormone-Sensitive Prostate Cancer Treatment

0:00 46:29

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Urology Times Podcasts?

This episode is 46 minutes long.

When was this Urology Times Podcasts episode published?

This episode was published on April 2, 2025.

Can I download this Urology Times Podcasts episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!